simAbs

SIMABS NV has developed a unique platform for fast, flexible and cost effective development and manufacturing of monoclonal antibodies. We deliver total solutions for your development and manufacturing by means of a new and unique manufacturing platform based on continuous bioprocessing. This platform allows us to produce several complex antibodies (monoclonal, bispecific, multivalent,...) in a range from milligrams to kilograms for biopharmaceutical companies. This platform will enable personalised medicine to become an affordable reality. We are a one stop shop with a lean and customer oriented project management approach. SIMABS offers additional services like: Cell line development USP/DSP development Analytical and formulation development Quality Management Validation Project Management Technology Transfer to GMP Regulatory Affairs Clinical Research Contact us to learn more about our pharmaceutical contract development and manufacturing capabilities